Chemical Structure : Senexin B
CAS No.: 1449228-40-3
货号: PC-42425Not For Human Use, Lab Use Only.
Senexin B (SNX2-1-165) is a highly potent, selective and orally available CDK8/CDK19 inhibitor with IC50 of 24-50 nM.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥1580 | In stock | |
10 mg | ¥2480 | In stock | |
25 mg | ¥3980 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Senexin B (SNX2-1-165) is a highly potent, selective and orally available CDK8/CDK19 inhibitor with IC50 of 24-50 nM.
Senexin B (SNX2-1-165) exhibits selectivity for CDK8 and CDK19 with Kd of 140 nM and 80 nM, respectively.
Senexin B (SNX2-1-165) significantly suppresses tumor growth in ER-positive breast cancer xenografts.
分子量 | 450.53 | |
分子式 | C27H26N6O | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
4-((2-(6-(4-Methylpiperazine-1-carbonyl)naphthalen-2-yl)ethyl)amino)quinazoline-6-carbonitrile |
1. Donald C. Porter, et al. Abstract PR08: Targeting tumor microenvironment with selective small-molecule inhibitors of CDK8/19.
2. Cdk8/cdk19 selective inhibitors and their use in anti-metastatic and chemopreventative methods for cancer. Publication number: WO2013116786 A1.
3. McDermott MS, et al. Oncotarget. 2017 Feb 21;8(8):12558-12575.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright